BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21038080)

  • 1. Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab.
    Ishikawa K; Nishihara H; Ozawa S; Piao CH; Ito Y; Kondo M; Terasaki H
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):273-80. PubMed ID: 21038080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide.
    Ishikawa K; Nishihara H; Ozawa S; Piao CH; Ito Y; Kondo M; Terasaki H
    Retina; 2009 Jun; 29(6):803-10. PubMed ID: 19262429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy.
    Ishikawa K; Kondo M; Ito Y; Kikuchi M; Nishihara H; Piao CH; Sugita T; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2254-9. PubMed ID: 17460288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.
    Aggio FB; Farah ME; Silva WC; Melo GB
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):215-20. PubMed ID: 17139490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.
    Ladewig MS; Karl SE; Hamelmann V; Helb HM; Scholl HP; Holz FG; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):17-25. PubMed ID: 17701197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Ahadi H
    Eur J Ophthalmol; 2008; 18(2):297-300. PubMed ID: 18320527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H; Taei R; Soheilian M; Riazi-Esfahani M; Karkhaneh R; Lashay A; Azarmina M; Dehghan MH; Moradian S
    BMC Ophthalmol; 2007 Jun; 7():10. PubMed ID: 17555600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
    Smretschnig E; Hagen S; Glittenberg C; Ristl R; Krebs I; Binder S; Ansari-Shahrezaei S
    Eye (Lond); 2016 Jun; 30(6):805-11. PubMed ID: 26965012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M; Shiragami C; Shiraga F; Kano M; Iida T
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HALF-DOSE PHOTODYNAMIC THERAPY COMBINED WITH BEVACIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee JH; Lee WK
    Retina; 2015 Aug; 35(8):1561-8. PubMed ID: 25768248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.
    Bashshur ZF; Schakal A; Hamam RN; El Haibi CP; Jaafar RF; Noureddin BN
    Arch Ophthalmol; 2007 Oct; 125(10):1357-61. PubMed ID: 17923543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Costagliola C; Romano MR; Rinaldi M; dell'Omo R; Chiosi F; Menzione M; Semeraro F
    Br J Ophthalmol; 2010 Feb; 94(2):180-4. PubMed ID: 19965822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
    Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
    Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.